Obesity drugs show promise for hormonal disorder PMOS

A small but growing body of research suggests GLP-1 drugs, commonly used for obesity, may also treat PMOS, a hormonal condition affecting 1 in 8 women. The medications improve insulin resistance, hormone balance, and ovulation, offering new hope for patients like 18-year-old Charlotte Touzalin, who participated in a study led by Dr. Melanie Cree.